Bellevue Medical Center is a hospital located in Bellevue, Sarpy County, Nebraska, United States. It opened on May 17, 2010.

There are 91 beds in Nebraska Medicine-Bellevue.

During the past decade, Nebraska Medicine-Bellevue conducted 46 clinical trials. In the 10-year time frame, 46 clinical trials started and 7 clinical trials were completed, i.e. on average, 15.2% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 7 clinical trials were completed. i.e. 35% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nebraska Medicine-Bellevue" #1 sponsor was "National Cancer Institute (NCI)" with 33 trials, followed by "ECOG-ACRIN Cancer Research Group" with 7 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "SWOG Cancer Research Network" with 4 trials sponsored and "University of Nebraska" with 4 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nebraska Medicine-Bellevue" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Brain Science Foundation" with 1 trials as a collaborator, "Division of Cancer Control" with 1 trials as a collaborator and "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Nebraska Medicine-Bellevue" are "Invasive Breast Carcinoma" (4 trials), "Stage II Breast Cancer" (3 trials), "Stage IIIA Breast Cancer" (3 trials), "Stage IIIB Breast Cancer" (3 trials) and "Stage IIIC Breast Cancer" (3 trials). Many other conditions were trialed in "Nebraska Medicine-Bellevue" in a lesser frequency.

Most popular intervention types in "Nebraska Medicine-Bellevue" are "Drug" (43 trials), "Other" (34 trials), "Biological" (26 trials), "Procedure" (26 trials) and "Radiation" (9 trials). Other intervention types were less common.

The name of intervention was led by "Biospecimen Collection" (14 trials), "Computed Tomography" (14 trials), "Nivolumab" (13 trials), "Quality-of-Life Assessment" (13 trials) and "Laboratory Biomarker Analysis" (12 trials). Other intervention names were less common.

The vast majority of trials in "Nebraska Medicine-Bellevue" are 48 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Nebraska Medicine-Bellevue". undefined are not yet recruiting, 18 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Nebraska Medicine-Bellevue, 2 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Nebraska Medicine-Bellevue, 1 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".